STIMULATE-ICP

United Kingdom of Great Britain and Northern Ireland
|
2022
  • Adults
  • General population
  • Community
  • SARS-CoV-2
  • Post-COVID-19
  • Colchicine
  • Antihistamines
  • Rivaroxaban

RECLAIM

The Netherlands
|
2025
  • Adults
  • Outpatient clinic
  • Community
  • Primary care
  • SARS-CoV-2
  • Post-COVID-19
  • Pharmacological intervention
  • Immunomodulator
  • Colchicine
  • Metformin